Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2781–2800 of 17,529 recalls

October 13, 2022· Akorn, Inc.

Recalled Item: Neomycin and Polymyxin B Sulfates

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: PAREMYD (hydroxyamphetamine hydrobromide/ tropicamide ophthalmic solution)...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5%

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Timolol Maleate Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears OINTMENT

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Ciprofloxacin Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 13, 2022· Aadi Bioscience

Recalled Item: Fyarro (sirolimus protein-bound particles for injectable suspension...

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 11, 2022· Fresenius Medical Care Holdings, Inc.

Recalled Item: 0.9% Sodium Chloride Injection

The Issue: Lack of Assurance of Sterility: Leakage of 0.9%

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 11, 2022· LNK International, Inc.

Recalled Item: NDC 0363-6171-09 Walgreens Sinus Pressure

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 7, 2022· Pharmacy Plus, Inc. dba Vital Care Compounder

Recalled Item: PAPAVERINE HCL STOCK SOLUTION 30MG/ML SOLUTION

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 7, 2022· Pharmacy Plus, Inc. dba Vital Care Compounder

Recalled Item: GLYCERIN OPHTHALMIC DROPS 98.5% Solution

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 7, 2022· Viatris Inc

Recalled Item: Octreotide Acetate Injection 500 mcg/mL

The Issue: Presence of Particulate Matter: Product complaint for the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
October 7, 2022· Pharmacy Plus, Inc. dba Vital Care Compounder

Recalled Item: MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension

The Issue: Lack of Assurance of Sterility: FDA inspection found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund